Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.89 - $20.97 $2.33 Million - $12.6 Million
-600,000 Reduced 85.71%
100,000 $1.27 Million
Q1 2024

May 15, 2024

SELL
$3.76 - $6.02 $2.63 Million - $4.21 Million
-700,000 Reduced 50.0%
700,000 $3.35 Million
Q4 2023

Feb 23, 2024

BUY
$4.8 - $7.67 $6.72 Million - $10.7 Million
1,400,000 New
1,400,000 $6.72 Million
Q3 2023

Nov 14, 2023

BUY
$6.81 - $9.74 $8.85 Million - $12.7 Million
1,300,000 New
1,300,000 $9.41 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $674M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.